Orthofix Medical Inc. Noncash or Part Noncash Acquisition, Fixed Assets Acquired
Orthofix Medical Inc. (OFIX) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $17.70 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2026-08-05
- Orthofix Medical Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2026-06-30 was $4.17M, a 22.34% decline year-over-year.
- Orthofix Medical Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2026-03-31 was $13.52M, a 140.73% increase year-over-year.
- Orthofix Medical Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-09-30 was $1.93M, a 52.81% increase year-over-year.
- Orthofix Medical Inc. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-06-30 was $5.37M.
| Period end | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 6 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 9 month |
|---|---|---|---|
| 2026-06-30 | $4.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $17.70M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $13.52M 10-Q · filed 2026-05-05 | ||
| 2025-09-30 | $1.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $7.30M derived: sum of 2 quarters · filed 2026-08-05 | $12.92M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $5.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $10.99M 10-Q · filed 2026-08-05 | |
| 2025-03-31 | $5.62M 10-Q · filed 2026-05-05 | ||
| 2024-09-30 | $1.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $7.26M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $6.00M 10-Q · filed 2025-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |